Literature DB >> 20222905

Macular abnormalities in patients with retinitis pigmentosa: prevalence on OCT examination and outcomes of vitreoretinal surgery.

Akira Hagiwara1, Shuichi Yamamoto, Kazuha Ogata, Takeshi Sugawara, Ayako Hiramatsu, Mamiko Shibata, Yoshinori Mitamura.   

Abstract

PURPOSE: To determine the prevalence of macular abnormalities detected by optical coherence tomography (OCT) in patients with retinitis pigmentosa (RP), and to report the results of pars plana vitrectomy (PPV) in five patients with RP.
METHODS: OCT images of the macula of 622 eyes of 323 patients with RP were evaluated. All patients had a complete clinical examination, and PPV was performed on two RP patients with a macular hole (MH), two patients with vitreomacular traction (VMT) syndrome, and one patient with cystoid macular oedema (CME).
RESULTS: A macular lesion was detected by OCT in 46 eyes (7.4%) of 37 patients (11.5%). CME was detected in 34 eyes (5.5%) of 26 patients, an epiretinal membrane in four eyes of four patients, VMT in five eyes of four patients, and full-thickness MH in three eyes of three patients. PPV was performed on five of these eyes. The MH was closed with vision improvement after a single surgery in one eye, and was closed after repeated PPVs with a decrease of vision in another eye. In both patients with VMT, the visual acuity decreased after the surgery. The macular morphology and visual acuity did not improve postoperatively on the one patient with CME who underwent PPV.
CONCLUSION: When OCT is used, macular abnormalities are present in 7.4% of patients with RP, which is lower than the prevalence reported earlier. Although vitrectomy can improve the macular morphology in some patients with RP, improvement of visual function may be limited most likely because of the long-standing retinal dysfunction.
© 2010 The Authors. Journal compilation © 2010 Acta Ophthalmol.

Entities:  

Mesh:

Year:  2011        PMID: 20222905     DOI: 10.1111/j.1755-3768.2010.01866.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  36 in total

1.  Spontaneous resolution of full-thickness macular hole in retinitis pigmentosa.

Authors:  Muhammad Raja; Craig Goldsmith; Benjamin J L Burton
Journal:  BMJ Case Rep       Date:  2011-07-27

2.  Clinical findings in a choroideremia patient who underwent vitrectomy for retinal detachment associated with macular hole.

Authors:  Hajime Shinoda; Takashi Koto; Keiko Fujiki; Akira Murakami; Kazuo Tsubota; Yoko Ozawa
Journal:  Jpn J Ophthalmol       Date:  2011-03-13       Impact factor: 2.447

Review 3.  Lamellar hole-associated epiretinal membrane is a common feature of macular holes in retinitis pigmentosa.

Authors:  Jingjing Liu; Jiao Lyu; Xiang Zhang; Peiquan Zhao
Journal:  Eye (Lond)       Date:  2019-08-27       Impact factor: 3.775

4.  Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.

Authors:  Buğra Karasu
Journal:  Int Ophthalmol       Date:  2019-11-26       Impact factor: 2.031

5.  Vitreo-macular interface disorders in retinitis pigmentosa.

Authors:  Serena Fragiotta; Tommaso Rossi; Carmela Carnevale; Alessandro Cutini; Stefano Tricarico; Lorenzo Casillo; Gianluca Scuderi; Enzo Maria Vingolo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-19       Impact factor: 3.117

6.  Macular hole in retinitis pigmentosa patients: microincision vitrectomy with polydimethylsiloxane as possible treatment.

Authors:  E M Vingolo; S Valente; E Gerace; L Spadea; M Nebbioso
Journal:  Eye (Lond)       Date:  2015-02-20       Impact factor: 3.775

Review 7.  Clinical characteristics and current therapies for inherited retinal degenerations.

Authors:  José-Alain Sahel; Katia Marazova; Isabelle Audo
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-16       Impact factor: 6.915

8.  Visual and morphological outcomes of vitreomacular traction syndrome in retinitis pigmentosa treated by vitrectomy.

Authors:  Feng Yan; Feng-Jie Xia; Feng Jiang; Hyeong Gon Yu
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

9.  En face OCT in Stargardt disease.

Authors:  Andrea Sodi; Dario Pasquale Mucciolo; Francesca Cipollini; Vittoria Murro; Orsola Caporossi; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-07       Impact factor: 3.117

Review 10.  CNGB1-related rod-cone dystrophy: A mutation review and update.

Authors:  Marco Nassisi; Vasily M Smirnov; Cyntia Solis Hernandez; Saddek Mohand-Saïd; Christel Condroyer; Aline Antonio; Laura Kühlewein; Melanie Kempf; Susanne Kohl; Bernd Wissinger; Fadi Nasser; Sara D Ragi; Nan-Kai Wang; Janet R Sparrow; Vivienne C Greenstein; Stylianos Michalakis; Omar A Mahroo; Rola Ba-Abbad; Michel Michaelides; Andrew R Webster; Simona Degli Esposti; Brooke Saffren; Jenina Capasso; Alex Levin; William W Hauswirth; Claire-Marie Dhaenens; Sabine Defoort-Dhellemmes; Stephen H Tsang; Eberhart Zrenner; Jose-Alain Sahel; Simon M Petersen-Jones; Christina Zeitz; Isabelle Audo
Journal:  Hum Mutat       Date:  2021-05-16       Impact factor: 4.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.